Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Axcelead
Deal Size : Undisclosed
Deal Type : Collaboration
xFOREST and Axcelead DDP Launch Joint Research on Small Molecule Drug Discovery
Details : The collaboration aims at developing RNA structure-targeted small molecule therapeutics for multiple diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 19, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Axcelead
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Otsuka Pharmaceutical
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the agreement, xFOREST will provide Otsuka with FOREST technologies to promote systemic, small-molecule drug discovery research targeting RNA structures. Otsuka will have exclusive rights to develop and commercialize RNA-targeted small molecules.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 13, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Otsuka Pharmaceutical
Deal Size : Undisclosed
Deal Type : Collaboration